{
    "root": "357ee4ea-1ab9-50e4-e063-6294a90afda2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Levetiracetam",
    "value": "20250519",
    "ingredients": [
        {
            "name": "MALTITOL",
            "code": "D65DG142WK"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "ACESULFAME POTASSIUM",
            "code": "23OV73Q5G9"
        },
        {
            "name": "AMMONIUM GLYCYRRHIZATE",
            "code": "3VRD35U26C"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "LEVETIRACETAM",
            "code": "44YRR34555"
        }
    ],
    "indications": "Levetiracetam oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Levetiracetam oral solution is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy (1.3)",
    "contraindications": "Use the oral solution for pediatric patients with body weight ≤ 20 kg (2.1) For pediatric patients, use weight-based dosing for the oral solution with a calibrated measuring device (not a household teaspoon or tablespoon) (2.1) Partial-Onset Seizures (monotherapy or adjunctive therapy) 1 Month to < 6 Months: 7 mg/kg twice daily; increase by 7 mg/kg twice daily every 2 weeks to recommended dose of 21 mg/kg twice daily (2.2) 6 Months to < 4 Years: 10 mg/kg twice daily; increase by 10 mg/kg twice daily every 2 weeks to recommended dose of 25 mg/kg twice daily (2.2) 4 Years to < 16 Years: 10 mg/kg twice daily; increase by 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily (2.2) Adults 16 Years and Older:  500 mg twice daily; increase by 500 mg twice daily every 2 weeks to a recommended dose of 1500 mg twice daily (2.2) Myoclonic Seizures in Adults and Pediatric Patients 12 Years and Older 500 mg twice daily; increase by 500 mg twice daily every 2 weeks to recommended dose of 1500 mg twice daily (2.3) Primary Generalized Tonic-Clonic Seizures 6 Years to < 16 Years: 10 mg/kg twice daily, increase in increments of 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily (2.4) Adults 16 Years and Older:  500 mg twice daily, increase by 500 mg twice daily every 2 weeks to recommended dose of 1500 mg twice daily (2.4) Adult Patients with Impaired Renal Function Dose adjustment is recommended, based on the patient’s estimated creatinine clearance (2.5 , 8.6)",
    "warningsAndPrecautions": "Levetiracetam Oral Solution USP, 100 mg/mL is a clear, colorless grape flavored liquid\n                  \n                  NDC: 70518-3803-00\n                  NDC: 70518-3803-01\n                  NDC: 70518-3803-02\n                  NDC: 70518-3803-03\n                  NDC: 70518-3803-04\n                  NDC: 70518-3803-05\n                  NDC: 70518-3803-06\n                  NDC: 70518-3803-07\n                  NDC: 70518-3803-08\n                  NDC: 70518-3803-09\n                  PACKAGING: 10 in 1 BOX\n                  PACKAGING: 7.50 mL in 1 CUP, UNIT DOSE\n                  PACKAGING: 10 in 1 BOX\n                  PACKAGING: 5 mL in 1 CUP, UNIT DOSE\n                  PACKAGING: 10 in 1 BOX\n                  PACKAGING: 12.50 mL in 1 CUP, UNIT DOSE\n                  PACKAGING: 10 in 1 BOX\n                  PACKAGING: 20 mL in 1 CUP, UNIT DOSE\n                  PACKAGING: 10 in 1 BOX\n                  PACKAGING: 15 mL in 1 CUP, UNIT DOSE\n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                  \n                  Dispense in a tight, light-resistant container with a child-resistant closure.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions": "Levetiracetam is contraindicated in patients with a hypersensitivity to levetiracetam. Reactions have included anaphylaxis and angioedema\n \n  [see\n  \n   Warnings and Precautions (5.4)]\n \n  ."
}